Esperion Therapeutics (United States)
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Esperion Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
43%
Total
Publications
175
Total Open
Publications
75
Total
Citations
12K
Open Access
Percentage
43%
Total
Publications
175
Total Open
Publications
75
Total
Citations
12K
Breakdown
Publisher Open
14%
Both
24%
Other Platform Open
4%
Closed
58%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
25
Hybrid 29%
19
No Guarantees 32%
21
Other Platform Open
Domain 73%
36
Institution 29%
14
Other Internet 8%
4
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 36 |
DOI | Other Internet | 4 |
DANS - Data Archiving and Networked Services | Institution | 4 |
Washington University School of Medicine - Digital Commons@Becker | Institution | 2 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 2 |
Europe PMC | Domain | 2 |
Università Cattolica del Sacro Cuore - PubliCatt | Institution | 1 |
University of Michigan - Deep Blue | Institution | 1 |
Saxon State and University Library Dresden - Qucosa | Institution | 1 |
Liverpool John Moores University | Institution | 1 |